Article Type
Article
Abstract
Background
 Odor identification is a complex process involving different neuronal mechanisms. It is important from different aspects of quality of life. Postviral neuritis is one of the leading causes of
 hyposmia. Attention to it has increased in the last year due to the coronavirus disease 2019
 pandemic. Systemic steroids are presumed to benefit such cases through its anti‑inflammatory
 mechanism of action. Cinnarizine, being a multimodal mechanism of action drug with a potent
 cerebral vasodilator effect, is assumed to have a great potential to be used as adjuvant
 treatment to systemic steroids.
 Objective
 The aim of the study is to assess if there is any role of Cinnarizine as an adjuvant treatment
 to steroids in cases of postviral hyposmia.
 Patients and methods
 This is a single‑blinded, randomized, controlled trial including 82 patients with postviral
 hyposmia. Patients were distributed equally into two groups according to the given therapy
 with group I receiving 25 mg oral prednisolone per day for 2 weeks along with budesonide
 nasal spray/64 µg per puff in a dose of two puffs for each nostril twice daily for 1 month, in
 addition to our drug of study Cinnarizine 25 mg given postoperative TDS for 1 month. Group II
 received the same but without Cinnarizine. Both groups were compared regarding the number
 and percentage of patients having their smell identification test score improved either partially
 or fully back to normal.
 Results
 Cinnarizine intake as an adjuvant treatment to steroids had a significant effect on improving the
 smell identification test scores in patients with postviral hyposmia (P˂0.05). However, among
 the improved patients in both groups, there was a nonsignificant difference between the two
 groups regarding the degree of recovery whether complete or partial (P=0.78).
 Conclusion
 Cinnarizine has a beneficial effect as an adjuvant treatment to steroids in cases of postviral
 hyposmia.
 Keywords:
 anosmia, hyposmia, olfaction Cinnarizine, olfactory, Stugeron
Recommended Citation
            Attia TM, Rawat V. 
    Role of Cinnarizine as an adjuvant treatment in cases of postviral hyposmia.
    Pan Arab J. Rhinol.
        2021;
    11 : 139-144.
           Available at:
        https://pajr.researchcommons.org/journal/vol11/iss2/14
    
            DOI: https://doi.org/10.4103/pajr.pajr_22_21
                
    
 
				 
					 
			 
			 
			 
			 
			 
			 
			 
			 
			 
			 
			 
			 
			 
			